Your prediction
Protalix Biotherapeutics Inc. Stock
The Protalix Biotherapeutics Inc. stock is trending slightly upwards today, with an increase of €0.010 (0.670%) compared to yesterday's price.
Our community identified positive and negative aspects for Protalix Biotherapeutics Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Protalix Biotherapeutics Inc. stock. On the other hand our users think that "Growth compared to competition" could be a problem in the future.
Pros and Cons of Protalix Biotherapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Protalix Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | 0.670% | 4.167% | -18.478% | -13.018% | -15.062% | 33.869% | -47.552% |
| Compugen Ltd. | -2.860% | 5.069% | -6.173% | -10.821% | -9.524% | 47.892% | - |
| Chromadex Corp | 0.910% | 0.000% | -9.756% | -7.500% | 7.767% | 273.989% | 20.130% |
| Intellia Therapeutics Inc | -4.250% | -6.699% | -6.061% | -40.633% | -32.354% | -79.776% | -82.519% |
